BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 33399935)

  • 21. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer.
    Tokuhisa M; Ichikawa Y; Kosaka N; Ochiya T; Yashiro M; Hirakawa K; Kosaka T; Makino H; Akiyama H; Kunisaki C; Endo I
    PLoS One; 2015; 10(7):e0130472. PubMed ID: 26208314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
    Kong Y; Ning L; Qiu F; Yu Q; Cao B
    Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical role of miR-421 as a novel biomarker in diagnosis of gastric cancer patients: A meta-analysis.
    Xu Y; Wang G; Hu W; He S; Li D; Chen P; Zhang J; Gao Y; Yu D; Zong L
    Medicine (Baltimore); 2022 May; 101(19):e29242. PubMed ID: 35583533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of tissue miR-338-3p predicts unfavorable prognosis of gastric cancer.
    Liu S; Suo J; Wang C; Sun X; Wang D; He L; Zhang Y; Li W
    Cancer Biomark; 2017 Dec; 21(1):117-122. PubMed ID: 29060930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. microRNA analysis of gastric cancer patients from Saudi Arabian population.
    Bibi F; Naseer MI; Alvi SA; Yasir M; Jiman-Fatani AA; Sawan A; Abuzenadah AM; Al-Qahtani MH; Azhar EI
    BMC Genomics; 2016 Oct; 17(Suppl 9):751. PubMed ID: 27766962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer.
    LArki P; Ahadi A; Zare A; Tarighi S; Zaheri M; Souri M; Zali MR; Ghaedi H; Omrani MD
    Iran Biomed J; 2018 Nov; 22(6):367-73. PubMed ID: 29859516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of candidate microRNAs in gastric cancer: A validation study.
    Zhang L; Huang Z; Zhang H; Zhu M; Zhu W; Zhou X; Liu P
    Cancer Biomark; 2017; 18(3):221-230. PubMed ID: 27983528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of circulating microRNAs as novel potential biomarkers for gastric cancer detection: a systematic review and meta-analysis.
    Zhu X; Lv M; Wang H; Guan W
    Dig Dis Sci; 2014 May; 59(5):911-9. PubMed ID: 24337687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of circulating miRNA biomarkers for predicting lymph node metastasis in gastric cancer.
    Kim SY; Jeon TY; Choi CI; Kim DH; Kim DH; Kim GH; Ryu DY; Lee BE; Kim HH
    J Mol Diagn; 2013 Sep; 15(5):661-9. PubMed ID: 23806809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hsa-miR-21 and Hsa-miR-29 in Tissue as Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer.
    Wang D; Fan Z; Liu F; Zuo J
    Cell Physiol Biochem; 2015; 37(4):1454-62. PubMed ID: 26509997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-Regulation of Plasma miR-23b is Associated with Poor Prognosis of Gastric Cancer.
    Zhuang K; Han K; Tang H; Yin X; Zhang J; Zhang X; Zhang L
    Med Sci Monit; 2016 Feb; 22():356-61. PubMed ID: 26835790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of diagnostic utility and molecular mechanisms of circulating miR-551b-5p in gastric cancer.
    Jiang X; Jiang M; Xu M; Xu J; Li Y
    Pathol Res Pract; 2019 May; 215(5):900-904. PubMed ID: 30732916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-183-5p acts as a potential prognostic biomarker in gastric cancer and regulates cell functions by modulating EEF2.
    Li W; Cui X; Qi A; Yan L; Wang T; Li B
    Pathol Res Pract; 2019 Nov; 215(11):152636. PubMed ID: 31558304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer.
    Cai H; Yuan Y; Hao YF; Guo TK; Wei X; Zhang YM
    Med Oncol; 2013 Mar; 30(1):452. PubMed ID: 23307259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum miR-515-3p, a potential new RNA biomarker, is involved in gastric carcinoma.
    Han X; Li X; Zhao H; Zhou D; Sun B; Liu A; Zhang J; Cui Z; Ma X; Yuan L
    J Cell Biochem; 2019 Sep; 120(9):15834-15843. PubMed ID: 31081157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression.
    Ahadi A
    IUBMB Life; 2020 May; 72(5):884-898. PubMed ID: 32078236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
    Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
    Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic association of gastric cancer with miRNA clusters including the cancer-related genes MIR29, MIR25, MIR93 and MIR106: results from the EPIC-EURGAST study.
    Espinosa-Parrilla Y; Muñoz X; Bonet C; Garcia N; Venceslá A; Yiannakouris N; Naccarati A; Sieri S; Panico S; Huerta JM; Barricarte A; Menéndez V; Sánchez-Cantalejo E; Dorronsoro M; Brennan P; Duarte-Salles T; B As Bueno-de-Mesquita H; Weiderpass E; Lund E; Clavel-Chapelon F; Boutron-Ruault MC; Racine A; Numans ME; Tumino R; Canzian F; Campa D; Sund M; Johansson M; Ohlsson B; Lindkvist B; Overvad K; Tjønneland A; Palli D; Travis RC; Khaw KT; Wareham N; Boeing H; Nesi G; Riboli E; Gonzalez CA; Sala N
    Int J Cancer; 2014 Nov; 135(9):2065-76. PubMed ID: 24643999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT.
    Wang R; Sun Y; Yu W; Yan Y; Qiao M; Jiang R; Guan W; Wang L
    J Exp Clin Cancer Res; 2019 Jan; 38(1):20. PubMed ID: 30646925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.